KVM Switch Market Projected to Cross USD 2.46 Billion by 2032, at Robust CAGR of 4.55% | Research by SNS Insider
December 06, 2024 08:00 ET
|
SNS Insider pvt ltd
Austin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Market Size & Growth Insights: According to the SNS Insider, “The KVM Switch Market Size was valued at USD 1.66 Billion in 2023 and is expected to...
The Conference Board of Canada: Aggressive Immigration Policy to Slow Growth
December 06, 2024 08:00 ET
|
The Conference Board of Canada
OTTAWA, Ontario, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The federal government’s revised immigration policy, which aims to dramatically reduce the number of non-permanent residents in Canada, will...
Workforce Analytics Market Size to Reach USD 7.26 Billion by 2031 | SkyQuest Technology
December 06, 2024 08:00 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Dec. 06, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Workforce Analytics Market Share will reach a value of USD 7.26 Billion by 2031, with a CAGR of 15.40% during the...
Interactive Display Market Size to Worth USD 90.66 Billion by 2032, with CAGR of 8.08% | Research by SNS Insider
December 06, 2024 08:00 ET
|
SNS Insider pvt ltd
Austin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Market Size & Growth Analysis: The SNS Insider report indicates that,“The Interactive Display Market Size was valued at USD 45.06 billion in 2023 and...
Biomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute Leukemia
December 06, 2024 08:00 ET
|
Biomea Fusion, Inc.
REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral...
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering
December 06, 2024 08:00 ET
|
Eyenovia, Inc.
NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging...
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
December 06, 2024 08:00 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin...
FluidForm Bio™ Announces Participation in the New England Venture Summit
December 06, 2024 08:00 ET
|
FluidForm Bio
WALTHAM, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will...
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
December 06, 2024 08:00 ET
|
Pacira BioSciences
PARSIPPANY, N.J., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the...
Playtika Holding Corp. to Participate in Upcoming Investor Conferences in Fourth Quarter 2024
December 06, 2024 08:00 ET
|
Playtika Holding Corp.
HERZLIYA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Playtika Holding Corp. (NASDAQ: PLTK) today announced that Craig Abrahams, Playtika’s President and Chief Financial Officer, will be participating...